Watch Ticker

Gossamer Bio, Inc. Common Stock

Go to Gossamer Bio, Inc. Common Stock Website

$2.16

0.00 (0.00%)

Live

Previous Close

$2.16

Day Range

$0 - $0

Previous Day Range

$2.0607 - $2.23

Market Cap

$493.2 million USD

Day Vol.

Previous Day Vol.

3.1 million

Currency

USD

Primary Exchange

Nasdaq

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include S...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight

The article discusses the evolving landscape of rare cardiovascular diseases, including Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy. It highlights the challenges in diagnosis and treatment, as well as the growing market size and pipeline of new therapies for these conditions.

Related tickers: ABBV, NVS, KNSA, JNJ, MRK, UTHR, LQDA, TENX, THC, GOSS, AVTE, INSM, CPIX, AZN.

Read Full Article

Globe Newswire - XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

XOMA Royalty Corporation has acquired Pulmokine Inc. for $20 million, adding the royalty and milestone interest in seralutinib, a Phase 3 asset being studied for pulmonary arterial hypertension, to its portfolio.

Related tickers: XOMA, XOMAO, XOMAP, GOSS.

Read Full Article

Trending Tickers

Please sign in to view